Stock·NASDAQ·Consumer Cyclical
Marriott International, Inc. (MAR)
- Market cap
- $101.19B
- P/E
- 39.89
- Dividend yield
- 0.72%
- Street target
- $393.00median of 28 analysts
- 52-week range
- $256.76 $410.98
The short version
Where MAR stands today, in four lines, and what CleaRank Financial AI makes of it.
MAR at a glance
Marriott International, Inc. (MAR): Buy, 65/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($351.97 and $352.21).
- Earnings MAR beat estimates in 5 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $70.7M and made no open-market purchases over the last 18 months.
- Valuation P/E of 39.9 against 20.8 for the Consumer Cyclical sector: a premium to peers (+92%).
Figures as of October 17, 2026.
CleaRank Financial AI
Marriott International, Inc. (MAR) carries a CleaRank rating of Buy and a model score of 65/100.
Trend adds the most to that score: the price is 10.17% above its 200-day average and 10.25% above its 50-day average. Valuation pulls the score down the most. The P/E of 39.89 sits 91.8% above the sector median (a premium to peers), and the P/S of 13.62 sits 616.8% above the sector median. The 50-day average is $351.97 and the 200-day average is $352.21. Across the past year, the price has risen 49.80%.
Only on CleaRank
Figures we compute ourselves from MAR's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $388.05 is 10.3% above the 50-day simple moving average of $351.97.Price above its 200-day average ›
The price is 10.2% above the 200-day simple moving average of $352.21.50-day average above the 200-day ›
The 50-day average ($351.97) is 0.1% below the 200-day average ($352.21), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 85% of its 52-week range, between $256.76 and $410.98.
MAR share price
Pick a period: each tab shows how far MAR has moved over it, to the last close.
Today's trading
Where MAR sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 39.89 is 91.8% above the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 13.62 is 616.8% above the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $2.6B on revenue of $7.4B, a net margin of 35.0%.Beat estimates in most recent reports ›
MAR beat the EPS estimate in 5 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 0.72%, or $2.80 a share a year.
Key statistics
The headline figures for MAR.
As of October 17, 2026, MAR trades at $388.05, with a market value of $101.19B, a P/E ratio of 39.89 and a dividend yield of 0.72%.
What the numbers say
CleaRank Financial AI's reading of MAR's valuation, growth and risks.
MAR changes hands at 39.89 times trailing earnings, which places its P/E 91.8% above the Consumer Cyclical median of 20.8. The peer comparison on this page calls that a premium to peers. On sales, the stock trades at 13.62 times, 616.8% above the sector median of 1.9. Put simply, each share carries trailing earnings of $9.67.
With revenue growth of 11.10%, MAR is 3.9 percentage points faster than the sector median of 7.2%. The business converts sales into profit at a net margin of 35.03% and an operating margin of 65.28%. Shareholders' capital earns -68.97%, below the sector median of 12.4%, measured as return on equity. The balance sheet and payout round out the picture, with a trailing dividend yield of 0.72% ($2.80 a share a year).
EPS of $3.19 versus the $3.08 analysts expected made the August 3, 2026 report a beat of 3.57%. The market reacted the other way, with the stock falling 0.47% the following session.
MAR has beaten the EPS estimate in 5 of its last 7 reports. Even so, the stock fell in the first session after 1 of those 5 beats. Analysts forecast EPS of $11.73 for this fiscal year, a growth of 17.1%, and $13.16 for the year after, a growth of 12.1%.
With a P/E of 39.89, 91.8% above the sector median, MAR is priced as a premium to peers, which means weaker results would be judged against a high bar. MAR's daily returns have a 30-day standard deviation of 1.25%. Over the last 18 months insiders sold $70.7M of stock and bought none on the open market. Sales like these are often planned in advance, so they say less than purchases would.
MAR against the Consumer Cyclical sector
How MAR compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: MAR trades at a significant premium to sector peers (+92%), suggesting market expectations for superior growth or market position.
Return vs SPY: Since May 6, 2025, MAR has gained 54.0% against a gain of 36.6% for SPY.
Performance against SPY
MAR and the Consumer Cyclical sector fund over the same days.
Revenue and earnings
How much MAR sells, and how much of it becomes profit.
Revenue growth: Revenue grew 4.3% in FY2025 to $26.2B, from $25.1B a year earlier.
Profit margin: The net margin was 9.9% in FY2025, up from 9.5% the year before.
Profitable: MAR earned $2.6B in FY2025.
Earnings reality check
Did MAR beat what analysts expected, and how did the stock react?
Earnings record: MAR beat the analyst estimate in 5 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 3, 2026after close | $3.08 | $3.19 | +3.57% | -0.47% | +0.46% |
| Feb 10, 2026after close | $2.62 | $2.58 | -1.53% | -0.17% | -0.93% |
| Nov 4, 2025after close | $2.39 | $2.47 | +3.35% | +3.98% | +7.22% |
| Aug 5, 2025after close | $2.62 | $2.65 | +1.15% | +1.15% | +2.04% |
| May 6, 2025after close | $2.25 | $2.32 | +3.11% | +1.60% | +8.80% |
| Feb 11, 2025after close | $2.38 | $2.45 | +2.94% | +0.85% | -0.15% |
| Nov 4, 2024after close | $2.31 | $2.26 | -2.16% | +1.26% | +11.50% |
As of October 17, 2026, MAR has beaten the analyst EPS estimate in 5 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 3, 2026, came in 3.57% above the estimate and the stock moved -0.47% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 75.7, in overbought territory.RSI above 50 ›
An RSI of 75.7 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of MAR
The score, the reasoning behind it, and what could move the price next.
Marriott International, Inc. (MAR) is in an uptrend: at $388.05, it trades 10.25% above its 50-day average of $351.97 and 10.17% above its 200-day average of $352.21. The price sits near the top of its 52-week range, 5.58% below the high of $410.98 and 51.13% above the low of $256.76. The 50-day average sits 0.07% below the 200-day, which shows the recovery has not reached the longer-run averages.
MAR's 14-day RSI sits at 75.7, which is in the overbought zone, and its MACD line is positive. Performance backs up that momentum across every period shown. The price has climbed 5.96% over three months, 2.68% over six months and 49.80% over the past year. In the last session, volume came in 51.9% above its average while the price gained 0.61%.
Earnings beat ›
The August 3, 2026 report beat the EPS estimate by 3.57%, and the share price fell 0.47% in the first session after it.
Source: Earnings report, August 3, 2026New analyst coverage ›
CICC started coverage at Outperform on August 12, 2026.
Source: Analyst action, CICC, August 12, 2026
New analyst coverage ›
Wolfe Research started coverage at Peer Perform on September 2, 2026.
Source: Analyst action, Wolfe Research, September 2, 2026
- The two levels to track are the 52-week high of $410.98, which sits above the price, and the 20-day EMA of $363.53, which sits below it.
- The 14-day RSI reads 75.7, in the overbought zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- The share price dropped 0.47% in the first session after the August 3, 2026 report. Over the last 7 reports, MAR beat estimates in 5.
The uptrend rests on MAR staying above its 50-day average at $351.97 and its 200-day average at $352.21; a close below the 200-day would be the first crack in it. On a pullback, the first level the price would meet is the 20-day EMA at $363.53.
The 52-week high at $410.98 is the next level overhead. The RSI is stretched above the overbought line, so a cooling of momentum would not be unusual even inside the uptrend.
Technical indicators
Momentum and trend for MAR, from its daily closes.
As of October 17, 2026, with MAR at $388.05, its 14-day RSI is 75.7 (overbought territory), its 50-day simple moving average is $351.97 and its 200-day is $352.21.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What MAR moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, MAR's 1-year correlation of daily returns is +0.57 with S&P 500 (SPY), +0.46 with Nasdaq 100 (QQQ), +0.07 with Bitcoin (BTC) and +0.00 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
13 of 28 analysts rate it a buy or strong buy, 13 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $393.00 is 1.3% above the price.More buy ratings than three months ago ›
13 of 28 rate it a buy now, against 12 of 26 three months ago.
MAR Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 10, 2026 | Truist Securities | Maintains | Hold |
| Sep 2, 2026 | Wolfe Research | Initiates | Peer Perform |
| Aug 20, 2026 | UBS | Maintains | Neutral |
| Aug 12, 2026 | CICC | Initiates | Outperform |
| Aug 5, 2026 | Macquarie | Maintains | Neutral |
| Aug 4, 2026 | Mizuho | Maintains | Neutral |
As of October 17, 2026, 28 Wall Street analysts cover MAR: 13 rate it a buy or strong buy, 13 a hold and 2 a sell or strong sell. Their 12-month price targets range from $280.00 to $425.00, with a median of $393.00, 1.3% above the price of $388.05.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
MAR trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from MAR's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much MAR tends to move, against the market and on its own.
The long record
MAR's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.25% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 58.4%, from December 2019 to April 2020, regained by February 2021.Most 1-year holds ended higher ›
77% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $63,356, against $42,055 in the S&P 500 (SPY).
MAR Drawdowns & Recovery
As of October 17, 2026, MAR's worst peak-to-trough fall over the last 10 years with dividends reinvested was -58.4% (December 2019 to April 2020); it regained that peak by February 2021, 10 months after the low, and 77% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into MAR in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: MAR beat the S&P 500 over this period: $63,356 against $42,055.
A $10,000 investment in MAR in October 2016 would be worth about $63,356 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to MAR, and which have not.
Strongest month, November: an average of +11.68%, up in 10 of 10 years.
Weakest month, March: an average of -5.99%, up in 3 of 10 years.
This month, October: has averaged +1.86%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, MAR's strongest calendar month has been November (average +11.68%, up in 10 of 10 years) and its weakest March (average -5.99%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in MAR, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MAR today could grow to about $26,200 by 2036 in the base case, with a 90th-percentile outcome near $99,152 and a 10th-percentile outcome around $6,923. The simulation models price only; at today's 0.72% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
MAR Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $570 for MAR by 2030 in the base case, from $388 today (1.5x over 4 years). The 10th-percentile path ends near $246. These are outcomes of a Monte Carlo simulation run on MAR's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $281 | $427 | $651 | |
| 2028 | $259 | $470 | $853 | |
| 2029 | $250 | $518 | $1,074 | |
| 2030 | $246 | $570 | $1,324 | |
| 2031 | $245 | $628 | $1,610 |
Method: a lognormal simulation of MAR's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
MAR insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought MAR shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, MAR insiders reported 23 open-market sales worth $70.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Deborah Marriott Harrison
Director
|
Sell | 3.5K | $1.2M |
| Sep 25, 2026 | David Sheets Marriott
Director
|
Sell | 3.5K | $1.2M |
| Sep 25, 2026 | John Willard Marriott Jr
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 3.5K | $1.2M |
| Jun 30, 2026 | Aylwin B Lewis
Director
|
Grant | 9 | $3.6K |
| Jun 30, 2026 | Grant F Reid
Director
|
Grant | 39 | $14.5K |
| May 18, 2026 | Peggy Fang Roe
Officer
|
Sell | 3.0K | $1.1M |
| May 18, 2026 | John Willard Marriott Jr
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 52 | - |
| May 13, 2026 | Yibing Mao
Officer
|
Sell | 4.8K | $1.7M |
| May 11, 2026 | Isabella D. Goren
Director
|
Grant | 670 | - |
| May 11, 2026 | Deborah Marriott Harrison
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 670 | - |
| May 11, 2026 | Frederick A Henderson
Director
|
Grant | 670 | - |
| May 11, 2026 | David Shawn Hill
Officer
|
Grant | 174 | $61.0K |
| May 11, 2026 | Lauren R Hobart
Director
|
Grant | 670 | - |
| May 11, 2026 | Aylwin B Lewis
Director
|
Grant | 670 | - |
| May 11, 2026 | Margaret M Mccarthy
Director
|
Grant | 670 | - |
| May 11, 2026 | Grant F Reid
Director
|
Grant | 670 | - |
| May 11, 2026 | Horacio Rozanski
Director
|
Grant | 670 | - |
| May 11, 2026 | Susan C Schwab
Director
|
Grant | 670 | - |
| May 11, 2026 | Sean Tresvant
Director
|
Grant | 670 | - |
| May 8, 2026 | John Willard Marriott Jr
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 2.3K | - |
| Mar 31, 2026 | Aylwin B Lewis
Director
|
Grant | 11 | $3.6K |
| Feb 19, 2026 | Rajeev Menon
Officer
|
Sell | 3.5K | $1.2M |
| Feb 18, 2026 | William P Brown
Officer
|
Sell | 9.5K | $3.4M |
| Feb 18, 2026 | Rajeev Menon
Officer
|
Sell | 6.3K | $2.3M |
| Feb 18, 2026 | Benjamin T Breland
Officer
|
Sell | 2.0K | $716.1K |
| Feb 18, 2026 | Rajeev Menon
Officer
|
Option | 8.5K | $1.8M |
| Feb 17, 2026 | Anthony G Capuano
Chief Executive Officer
|
Sell | 63.0K | $22.6M |
| Feb 17, 2026 | David Sheets Marriott
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 4.7K | $1.7M |
| Feb 17, 2026 | Drew Pinto
Chief Technology Officer
|
Sell | 4.0K | $1.4M |
| Feb 13, 2026 | Rena Hozore Reiss
General Counsel
|
Sell | 2.5K | $896.8K |
| Feb 13, 2026 | Satyajit Anand
Officer
|
Grant | 2.5K | $900.1K |
| Feb 13, 2026 | Benjamin T Breland
Officer
|
Grant | 2.8K | $990.5K |
| Feb 13, 2026 | Anthony G Capuano
Chief Executive Officer
|
Grant | 13.0K | $4.6M |
| Feb 13, 2026 | David Shawn Hill
Officer
|
Grant | 846 | $300.0K |
| Feb 13, 2026 | Felitia Lee
Officer
|
Grant | 891 | $316.0K |
| Feb 13, 2026 | Yibing Mao
Officer
|
Grant | 1.1K | $375.6K |
| Feb 13, 2026 | Jennifer Mason
Chief Financial Officer
|
Grant | 2.5K | $900.1K |
| Feb 13, 2026 | Rajeev Menon
Officer
|
Grant | 1.2K | $420.2K |
| Feb 13, 2026 | Drew Pinto
Chief Technology Officer
|
Grant | 1.5K | $540.5K |
| Feb 13, 2026 | Rena Hozore Reiss
General Counsel
|
Grant | 2.2K | $795.8K |
| Feb 13, 2026 | Peggy Fang Roe
Officer
|
Grant | 1.5K | $540.5K |
| Feb 12, 2026 | Anthony G Capuano
Chief Executive Officer
|
Grant | 84.5K | - |
| Feb 11, 2026 | Satyajit Anand
Officer
|
Grant | 4.5K | - |
| Feb 11, 2026 | Benjamin T Breland
Officer
|
Grant | 13.5K | - |
| Feb 11, 2026 | William P Brown
Officer
|
Grant | 13.5K | - |
| Feb 11, 2026 | Yibing Mao
Officer
|
Grant | 4.7K | - |
| Feb 11, 2026 | Rajeev Menon
Officer
|
Grant | 4.5K | - |
| Feb 11, 2026 | Kathleen K Oberg
Chief Financial Officer
|
Grant | 19.2K | - |
| Feb 11, 2026 | Drew Pinto
Chief Technology Officer
|
Grant | 6.8K | - |
| Feb 11, 2026 | Rena Hozore Reiss
General Counsel
|
Grant | 11.3K | - |
| Feb 11, 2026 | Peggy Fang Roe
Officer
|
Grant | 6.8K | - |
| Dec 31, 2025 | Aylwin B Lewis
Director
|
Grant | 11 | $3.6K |
| Dec 31, 2025 | Yibing Mao
Officer
|
Option | 3.9K | $1.2M |
| Dec 31, 2025 | Yibing Mao
Officer
|
Grant | 1.9K | $578.6K |
| Dec 15, 2025 | Felitia Lee
Officer
|
Sell | 1.6K | $494.8K |
| Dec 12, 2025 | Deborah Marriott Harrison
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 5.5K | - |
| Dec 4, 2025 | David Sheets Marriott
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 488 | - |
| Dec 3, 2025 | Deborah Marriott Harrison
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 2.2K | - |
| Dec 3, 2025 | John Willard Marriott Jr
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 123 | - |
| Nov 25, 2025 | Felitia Lee
Officer
|
Sell | 873 | $263.3K |
| Nov 17, 2025 | John Willard Marriott Jr
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 5.5K | - |
| Nov 12, 2025 | David Sheets Marriott
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 850 | - |
| Nov 11, 2025 | Deborah Marriott Harrison
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 70.0K | $20.4M |
| Nov 10, 2025 | Peggy Fang Roe
Officer
|
Sell | 2.0K | $584.2K |
| Nov 10, 2025 | Benjamin T Breland
Officer
|
Grant | 11 | - |
| Nov 7, 2025 | Rena Hozore Reiss
General Counsel
|
Sell | 5.5K | $1.6M |
| Nov 7, 2025 | Benjamin T Breland
Officer
|
Sell | 1.7K | $472.1K |
| Nov 7, 2025 | Satyajit Anand
Officer
|
Option | 6.7K | $449.6K |
| Nov 7, 2025 | Rena Hozore Reiss
General Counsel
|
Option | 20.1K | $2.7M |
| Nov 6, 2025 | William P Brown
Officer
|
Sell | 6.7K | $1.9M |
| Sep 30, 2025 | Aylwin B Lewis
Director
|
Grant | 13 | $3.6K |
| Aug 26, 2025 | Peggy Fang Roe
Officer
|
Grant | 200 | - |
| Jun 30, 2025 | Aylwin B Lewis
Director
|
Grant | 13 | $3.6K |
| Jun 24, 2025 | Rajeev Menon
Officer
|
Sell | 2.5K | $670.7K |
| May 30, 2025 | Anthony G Capuano
Chief Executive Officer
|
Sell | 12.0K | $3.2M |
| May 13, 2025 | Benjamin T Breland
Officer
|
Sell | 1.9K | $504.0K |
| May 12, 2025 | Isabella D. Goren
Director
|
Grant | 868 | - |
| May 12, 2025 | Deborah Marriott Harrison
Director
|
Grant | 868 | - |
| May 12, 2025 | Frederick A Henderson
Director
|
Grant | 868 | - |
| May 12, 2025 | Lauren R Hobart
Director
|
Grant | 868 | - |
| May 12, 2025 | Debra L Lee
Director
|
Grant | 868 | - |
| May 12, 2025 | Aylwin B Lewis
Director
|
Grant | 868 | - |
| May 12, 2025 | Margaret M Mccarthy
Director
|
Grant | 868 | - |
| May 12, 2025 | Grant F Reid
Director
|
Grant | 868 | - |
| May 12, 2025 | Horacio Rozanski
Director
|
Grant | 868 | - |
| May 12, 2025 | Susan C Schwab
Director
|
Grant | 868 | - |
| May 12, 2025 | Sean Tresvant
Director
|
Grant | 868 | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.